HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kimiyo Takeshita Selected Research

KE 758

2/2002Effects of a new anti-rheumatic drug KE-298 and its active metabolite: KE-758 on secretion of thioredoxin and on the level of intracellular glutathione in human monocytes and T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kimiyo Takeshita Research Topics

Disease

1T-Cell Leukemia (Leukemia, T Cell)
02/2002

Drug/Important Bio-Agent (IBA)

1esonarimodIBA
02/2002
1KE 758IBA
02/2002
1Acetylcysteine (Siran)FDA LinkGeneric
02/2002
1Antirheumatic Agents (DMARD)IBA
02/2002